Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2017.01.062
Abstract: BACKGROUND Quadrivalent live attenuated influenza vaccine (Q/LAIV) was licensed in 2012 and replaced trivalent live attenuated influenza vaccine in the United States during the 2013-2014 influenza season. This study assessed the safety of Q/LAIV in… read more here.
Keywords: influenza vaccine; safety; aged 49years; attenuated influenza ... See more keywords